PUBLICATIONS

AI in Clinical Trials: 8 Groundbreaking Innovations That Defined the Year As the new year unfolds, the field of clinical research is charging forward with a wave of powerful innovations, driven by the integration of artificial intelligence. In the past year alone, AI has demonstrated its potential to redefine key aspects of drug development—from patient recruitment to protocol optimization. These innovations are not just enhancing efficiency Read more

Advancing Lung Cancer Care: New Treatment Insights Highlighted During Awareness Month As Lung Cancer Awareness Month brings attention to the disease, the impact of lung cancer worldwide remains grave, with around 1.8 million lives lost each year. Recent findings in cancer research bring encouraging news: a new combination therapy of amivantamab and lazertinib offers a substantial improvement for those with advanced non-small cell lung cancer (NSCLC). Read more

World Diabetes Day Focus: The Role of GLP-1 Agonists and SGLT2 Inhibitors in Diabetes Treatment Key takeaways:  GLP-1 Agonists and SGLT2 Inhibitors are two effective medication classes for managing Type 2 diabetes, each offering unique benefits.  GLP-1 Agonists (e.g., Ozempic) provide significant blood sugar control and weight loss, ideal for patients prioritizing weight management.  SGLT2 Inhibitors (e.g., Jardiance) offer strong heart and kidney protection, often recommended for patients with heart Read more

Clinical Research Focus. 34th Edition Navigating the EU Clinical Trials Regulation: Insights and Challenges for Sponsors         The EU Clinical Trials Regulation is reshaping the clinical trial landscape, offering a more streamlined and transparent process while introducing new challenges for sponsors. In this interview, Cromos Pharma’s EU Regulatory Lead, Monika David, discusses how the CTR harmonizes trial processes, the Read more